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T IS RECOGNIZED that tests for rheuma-I toid factors are less often positive in juvenile rheumatoid arthritis (JRA) than in the adult form of the disease. The explanation for this discrepancy is not completely clear. Those children who develop seropositivity may constitute a separate group of patients from the standpoint of diagnosis or prognosis. Ideally, to ascertain this, children with arthritis would be followed with serial rheumatoid ' factor tests well into adulthood. Data from this type of approach are not available at the present time. As a partial solution to this problem, a crosssectional group of patients with JRA of various ages and differing durations of disease activity has been examined. It is intended that such a composite view of the disease will approximate data that might have been obtained from the more desirable, longitudinal investigation.
MATERIALS AND METHODS
The study group consisted of 110 children and adults with rheumatoid arthritis, all of whom had onset of disease at or before 14 years of age. Seventy-seven were females. Eighty-four were currently under care at The University of Michigan Medical Center. Twenty-six who had not been seen for at least five years were selected at random and recalled in order to obtain patients with longer duration of disease, and to determine whether patients currently under observation might have disease of greater severity. A complete physical examination was done on each patient to delineate current status of disease and functional capacity. Each subject was to have a minimum of two sera, separated by at least one year, drawn during the five year period of the study, 1961 through 1965. All positive results were verified by repeat examination of another serum.
For convenience in analysis, the patients were divided into three groups according to type of onset. Those categorized as having polyarticular disease had more than two joints objectively involved from the onset and otherwise met the criteria were then performed in a solution of pH 8.2 containing 0.1 M glycine, 0.585 per cent NaC1, and 0.4 per cent bovine serum albumin. After incubation at 56 C. for 90 minutes, the tubes were maintained at room temperature for 20 hours, centrifuged at 1400 X g for 3 minutes, and read without agitation. A titer of 1:20 or more was considered positive. The Hyland rapid slide latex agglutination test (HST) was performed as described (Hyland RA-Test, Hyland Laboratories, Los Angeles, Calif.). In the group of patients with rheumatoid arthritis, a positive rheumatoid factor test was defined for correlations with the clinical aspects of the disease as a positive HEAT or LFT. The LFT 56 and HST were excluded from consideration in these analyses.
Total serum proteins were done by a biuret method, and paper electrophoresis was carried out on the Beckman Model R Paper Electrophoresis Apparatus. Quantitation was performed with a Spinco Analytrol. A patient with a concentration of gamma globulins of 1.5 Gm./100 ml.
or greater was judged to have hypergammaglobulinemia. L.E. cell preparations were done according to the technic of Fallet and ZiE.4
RESULTS
TabIe 1 includes data from the general population profile. In the children 0 to 4 years of age, two had minimally positive titers in the HEAT (1:32) and another had a significantly positive LFT (1:2,560). In the rest of the control group, the number of positive tests increased with age in accord with previous population surveys. The incidence of seropositivity in the LFT 56 increased markedly after 14 years of age. In Table 2 are listed 34 children with connective tissue diseases other than rheumatoid arthritis. Twelve were seropositive. In the group of 175 hospitalized children, the LFT was positive in 1.1 per cent.
Within the group of 110 patients with JRA, 102 had two or more serologic examinations separated by at least one year. Eight patients were tested on only one occasion. The distribution of positive rheumatoid factor tests is shown in Table 3 . A considerable discrepancy in results was apparent among the various test systems. The HST was negative in the presence of a positive HEAT or LFT in 6.3 per cent of the patients and, conversely, was positive in 3.6 per cent in whom the HEAT and LFT were negative.
Twenty-four patients, 5 males and 19 females, had a positive HEAT or LFT or both during the course of the study. Twenty-two had strongly positive tests, and two were positive in minimally significant titer. There were two Negroes in the total group and one was seropositive. Sixteen patients were consistently positive, and four negative sera converted to positive. In this Correlations between positive rheumatoid factor tests and the age-dependent parameters of the patient group are shown in Table 4 . The age of the patient at the time of the initial serum is presented in the first column. Half of the study group was younger than 12 years of age. Twenty-two per cent of all the patients were seropositive; however, the number of positive tests increased with advancing age. Five per cent of the children younger than 12 years of age and 38 per cent of those over 12 had positive tests. There was a significant correlation of seropositivity with age of the patient, and positive sera were not encoun- The age of onset of JRA for the study group is shown in the second column of Table 4 . The peak age of onset was two to three years with a median of six years. Late onset of disease was clearly associated with seropositivity. Six patients who had onset of disease before seven years of age were, however, seropositive when tested later in life. Three were adults at the time of this study, but the others were 7, 10, and 14 years of age, This finding suggested that at least some of the children in the youngest age group would develop seropositivity if followed long enough. The relationship between duration of disease and seropositivity is detailed in the third column. Duration included the total period of continuous or intermittent activity. Although 55 per cent of the children had active disease for five years or more, one-third of the seropositive group was within the initial five years of active disease. Seropositivity therefore did not correlate with duration of disease. At the end of the study, 17 patients were in remission. Two of these were still seropositive. Only one patient died during the five year period, a 12-year-old girl with seronegative systemic disease.
A polyarticular onset probably did not correlate with seropositivity ( x2[zl = 5.812; p = 0.05-0.10). Thirty-one per cent of 54 patients with polyarticular onset had positive rheumatoid fadm tests. The respective numibiers were 14 pelr cent for Ithe 14 with systemic onset and 12 per cent for the 42 with monarticular disease. The results relative to functional capacity are listed in Table 5 . Although there was only one positive serum in Class I, seropositivity probably was not correlated with an increasing degree of functional impairment ( x~~~~ = 7.045; p = 0.05-0.10). Forty-three patients were found to have unequivocal erosions of bone on roentgenograms. Thirty-three per cent of this number had positive rheumatoid factor tests, and 15 per cent of those without this change were positive. Seropositivity was therefore probably not associated with erosive bone disease ( x2[,, = 3.796; p = 0.05-0.10). Moreover, the groups with and without bone erosion were not comparablle in respect to median age and duration of disease (18 and 8 years for the first group and 9 and 3 years for the second). Both seropositivity and bone erosion increased in incidence with advancing age of the patient group.
The level of gamma globulins in each serum was compared with seropositivity and with the type of onset of the disease. Thirty-five patients with polyarticular onset, 21 with monarticular, and 10 with systemic had elevated levels of gamma globulins. In no case was there a positive cor- There was no correlation of seropositivity with band keratopathy (1/9). Eighty-two per cent of 11 patients with rheumatoid nodules had positive rheumatoid factor tests. Fifteen per cent of those without nodules were positive. This is a highly significant association (xZLl1 = 22.034; p < .001). Nodules furthermore tended to be associated with small joint disease (MCP and PIP) and with late age of onset. The 12 patients that were positive in all four tests had predominantIy polyarticular disease with small joint involvement of relatively late age of onset. There was in addition a definite trend towards an increased percentage of nodules, bone destruction, elevated serum gamma globulins, and impaired functional capacity.
The therapeutic programs were evaluated and did not appear to affect the serologic reactions. The patients were treated for the most part conservatively with acetylsalicylic acid. One patient in the group with positive rheumatoid factor tests was on aurothioglucose, three were on hydroxyrhloroquine, and two on adrenocorticosteroids. In the patients with negative tests, four were on gold, 12 on hydroxychlorop i n e , and 13 on steroids.
LFT or both. This ratio is comparable to that found in population studies on adult rheumatoid arthritis, but is approximately half the expected ratio for clinic adult rheumatoid arthritis patients. The cumulative incidence of 38 per cent seropositivity in the adult patients with JRA was less than the 75 per cent that would be expected in a comparable group with postpubertal onset of the disease. No additional information was obtained by comparing the distribution of titers in the test systems to the controls. The low percentage of seropositivity in JRA may reflect one of the following suppositions: The age of the patient is the predominant factor in determining seropositivity; the juvenile group reflects a greater proportion of the total pool of these patients present in a population than do the clinic patients with adult onset of rheumatoid arthritis; or this disease category in children is different from the disease as defined for adults. The significance of the LFT 56 is uncertain at this time. It is likely that the antibody is an anti-IgG 19s macroglobulin similar or identical to rheumatoid f a~t o r .~ In this study the LFT 56 was less specific, although more sensitive, than the HEAT and LFT. The percentage of positivity in the patients was 57 per cent as compared to 25 per cent in the population controls weighted for age.
Reports in the literature of rheumatoid factor tests in patients with juvenile rheumatoid arthritis are in general agreement with this study. Selected aspects of some of the larger series are summarized in Table  6 . In order to facilitate a more direct comparison of results with the present study, the data provided by these reports have been analyzed by comparable statistical methods.
During 4 to 8 years, the differential sheep cell agglutination test was p e r f o m d on 142 patients seen at the Rheumatism Research Unit at Taplow.6 Sixty-four patients had positive tests at some time during the
DISCUSSION
In comparison with the controls in Table   1 weighted for age, 5.5 times as many patients with JRA had a positive HEAT or study. Of this number, 35 had negative results in the first year and became positive later. In a comparison of the same group of children with adult patient^,^ 50 per cent of adults were seropositive on first testing compared with 13.4 per cent of children. In a report from New York City,* the sensitized sheep cell agglutination test was positive in 40 per cent of 45 patients and the latex fixation test in 13 per cent of 31 patients with JRA. The incidence of positive tests was greater in patients with arthritis for more than five years, and there was a positive association with the age of the patient. There were four positive sensitized cell tests in six patients with subcutaneous nodules. The titers were not significantly higher in patients with systemic disease.
In a series of 100 children and 100 adults with JRA treated between 1960 and 1862 at the Rheumatism Foundation Hospital, Heinola, Finland,s the Waaler-Rose and in most instances negative if onset had occurred before six years of age irrespective of the patient's present age. There was no increase in percentage of positivity with advancing age of onset in the latter group, as was the case in the present study; therefore, the relation between late age of onset and seropositivity was primarily due to the results observed in the adult group. Laaksonen found the latex slide test positive in 29.5 per cent of 363 patients and the Waaler-Rose reaction in 11.2 per cent of a group of 384 with JRA studied at the same Rheumatism Foundation Hospital from 1951-61.lO There was 7.6 per cent positivity in children with onset at less than six years of age and 54 per cent in those with onset after the age of six. Seropositivity correlated with a poor prognostic outlook. Only one patient in the oligoarticular category had a positive latex fixation test, and those with persistently monarticular course were seronegative. latex fixation tests were markedly more positive in the adult group. The tests were Except for the ability to prevent or cure rheumatoid arthritis, accurate prognostica- 
